Ignite Creation Date:
2024-05-06 @ 3:50 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04773782
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-06-15
First Post:
2021-02-09
Brief Title:
A Study of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signaling
Sponsor:
Blueprint Medicines Corporation
Organization:
Blueprint Medicines Corporation
Organization Data
Organization:
Blueprint Medicines Corporation
Class:
INDUSTRY
Study ID:
BLU-285-3101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Blueprint Medicines Corporation
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None